Clinical Trials Directory

Trials / Completed

CompletedNCT05300568

A Survey About Trade-offs When Choosing Menopause Treatments

Women's Treatment Preferences for Moderate to Severe Vasomotor Symptoms (VMS) (WARMER Study)

Status
Completed
Phase
Study type
Observational
Enrollment
1,465 (actual)
Sponsor
Astellas Pharma Europe Ltd. · Industry
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is an online survey of women in menopause with moderate to severe hot flashes. Menopause, a normal part of life, is the time after a woman's last period. Hot flashes often occur during menopause. They can disrupt a woman's daily life. This study is about collecting information only. There will be no treatment in this study. This study will provide information on the trade-offs women are willing to make when deciding which treatment or treatments work best for them. Women from Australia, Canada, Denmark, France, Germany, Italy, Spain, Sweden and the United Kingdom (UK) will take part in this study. Women will be recruited through a third-party recruitment company. Most women will be asked to complete an online survey. Before the survey is sent to the women in the study, it will be tested by a small group of women. This group will be asked to take part in a telephone interview while taking the survey. They will be asked to say their thoughts aloud while completing the survey. Researchers will record this and also take notes. The aim of the interview is to check that the survey is understood by the women before it is sent out to the rest of the women. The survey will have 3 sections: Firstly, the women will answer questions about their experience with menopause and their symptoms. Next, they will be shown pros and cons for specific treatments for their menopause symptoms. The women will be asked to choose which treatment they would prefer, based on this information. Finally, they will answer questions on how their menopause symptoms have impacted their lives.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionThis is a non-product related survey.

Timeline

Start date
2022-08-17
Primary completion
2023-08-27
Completion
2023-08-27
First posted
2022-03-29
Last updated
2024-10-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05300568. Inclusion in this directory is not an endorsement.